Evidence map›Paper›PMID 38385988›Full record

ArticleThe Journal of general physiology2024

Phosphorylation of RyR2 simultaneously expands the dyad and rearranges the tetramers.

Parisa Asghari, David R L Scriven, Saba Shahrasebi, Hector H Valdivia, Katherina M Alsina, Carmen R Valdivia, J Alberto Navarro-Garcia, Xander H T Wehrens, Edwin D W Moore

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Decreased RYR2 Cluster Size and Abnormal SR CaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Parisa AsghariDepartment of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada.ORCID 0000-0003-2285-3242
David R L ScrivenDepartment of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada.ORCID 0000-0003-1828-1405
Saba ShahrasebiDepartment of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada.ORCID 0009-0003-3396-6805
Hector H ValdiviaDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.ORCID 0000-0003-1231-6267
Katherina M AlsinaCastle Biosciences Inc. , Friendswood, TX, USA.ORCID 0009-0005-3643-5350
Carmen R ValdiviaDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.ORCID 0000-0003-1224-3088
J Alberto Navarro-GarciaDepartment of Integrative Physiology, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-0317-4888
Xander H T WehrensDepartment of Integrative Physiology, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-5044-672X
Edwin D W MooreDepartment of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada.ORCID 0000-0001-7519-5592
University of British Columbia · CABaylor College of Medicine · USUniversity of Wisconsin–Madison · US

Funding

Ryanodine Receptors, Calcium-dependent Arrhythmias & HCMR01HL055438 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI VALDIVIA, HECTOR H · 1996 to 2023
$8.0M
Rational Design from Cryo-EM Structures of High-Affinity Ryanodine Receptor Ligands Based on Natural PeptidesR01HL170144 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Hector H Valdivia · 2023 to 2026
$2.6M
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent ArrhythmiasR01HL167195 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Francisco J Alvarado, Hector H Valdivia · 2023 to 2026
$2.4M
Junctophilin-2 cleavage in ischemic heart diseaseR01HL153350 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2021 to 2024
$2.3M
Mechanisms underlying atrial fibrillation associated with chronic kidney diseaseR01HL147108 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LI, NA, WEHRENS, XANDER H.T. · 2019 to 2022
$2.0M
CIHR 148527NHLBI NIH HHS R01 HL055438NHLBI NIH HHS R01 HL147108NHLBI NIH HHS R01 HL153350NHLBI NIH HHS R01 HL167195NHLBI NIH HHS R01 HL170144NIH HHS R01-HL055438
6 · The paper itself

Abstract

We have previously demonstrated that type II ryanodine receptors (RyR2) tetramers can be rapidly rearranged in response to a phosphorylation cocktail. The cocktail modified downstream targets indiscriminately, making it impossible to determine whether phosphorylation of RyR2 was an essential element of the response. Here, we used the β-agonist isoproterenol and mice homozygous for one of the following clinically relevant mutations: S2030A, S2808A, S2814A, or S2814D. We measured the length of the dyad using transmission electron microscopy (TEM) and directly visualized RyR2 distribution using dual-tilt electron tomography. We found that the S2814D mutation, by itself, significantly expanded the dyad and reorganized the tetramers, suggesting a direct link between the phosphorylation state of the tetramer and its microarchitecture. S2808A and S2814A mutant mice, as well as wild types, had significant expansions of their dyads in response to isoproterenol, while S2030A mutants did not. In agreement with functional data from these mutants, S2030 and S2808 were necessary for a complete β-adrenergic response, unlike S2814 mutants. Additionally, all mutants had unique effects on the organization of their tetramer arrays. Lastly, the correlation of structural with functional changes suggests that tetramer-tetramer contacts play an important functional role. We thus conclude that both the size of the dyad and the arrangement of the tetramers are linked to the state of the channel tetramer and can be dynamically altered by a β-adrenergic receptor agonist.

Indexed as

Ryanodine Receptor Calcium Release ChannelAnimalsIsoproterenolMiceMutationPhosphorylationIsoproterenolryanodine receptor 2. mouseRyanodine Receptor Calcium Release Channel

Identifiers

PMID38385988
PMCPMC10883851
OpenAlexW4392043536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.